dc.date.accessioned | 2021-11-22T16:23:29Z | |
dc.date.available | 2021-11-22T16:23:29Z | |
dc.date.created | 2021-11-10T14:04:24Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Castanon, Alejandra Rebolj, Matejka Burger, Emily Annika de Kok, Inge Smith, Megan A Hanley, Sharon Carozzi, Francesca Peakcock, Stuart O'Mahony, James . Cervical screening during the COVID-19 pandemic: optimising recovery strategies. The Lancet Public Health. 2021 | |
dc.identifier.uri | http://hdl.handle.net/10852/89277 | |
dc.description.abstract | Disruptions to cancer screening services have been experienced in most settings as a consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by temporarily expanding capacity; however, in practice, this is often not possible. We aim to inform the deliberations of decision makers in high-income settings regarding their cervical cancer screening policy response. We caution against performance measures that rely solely on restoring testing volumes to pre-pandemic levels because they will be less effective at mitigating excess cancer diagnoses than will targeted measures. These measures might exacerbate pre-existing inequalities in accessing cervical screening by disregarding the risk profile of the individuals attending. Modelling of cervical screening outcomes before and during the pandemic supports risk-based strategies as the most effective way for screening services to recover. The degree to which screening is organised will determine the feasibility of deploying some risk-based strategies, but implementation of age-based risk stratification should be universally feasible. | |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Cervical screening during the COVID-19 pandemic: optimising recovery strategies | |
dc.type | Journal article | |
dc.creator.author | Castanon, Alejandra | |
dc.creator.author | Rebolj, Matejka | |
dc.creator.author | Burger, Emily Annika | |
dc.creator.author | de Kok, Inge | |
dc.creator.author | Smith, Megan A | |
dc.creator.author | Hanley, Sharon | |
dc.creator.author | Carozzi, Francesca | |
dc.creator.author | Peakcock, Stuart | |
dc.creator.author | O'Mahony, James | |
cristin.unitcode | 185,52,11,0 | |
cristin.unitname | Avdeling for helseledelse og helseøkonomi | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.cristin | 1953240 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=The Lancet Public Health&rft.volume=&rft.spage=&rft.date=2021 | |
dc.identifier.jtitle | The Lancet Public Health | |
dc.identifier.doi | https://doi.org/10.1016/S2468-2667(21)00078-5 | |
dc.identifier.urn | URN:NBN:no-91880 | |
dc.type.document | Tidsskriftartikkel | |
dc.source.issn | 2468-2667 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/89277/1/Castanan2021_CovidCC_Viewpoint.pdf | |
dc.type.version | PublishedVersion | |